Abstract:e15597 Background: To report the long-term outcomes of Chinese rectal cancer patients after Watch and Wait (W&W) following neoadjuvant therapy(NAT). Methods: Collecting real-world multicenter retrospective data, including the Chinese W&W Database group (CWWD) and data from centers that initiated this work earlier in China. Patients with a follow-up time of no less than 2 years were included. Analyzing and reporting on their oncological outcomes and comparing differences between cCR and near-cCR groups. Results: The study included 318 rectal cancer patients from 8 institutions who received NAT and underwent W&W. Among them, 291 initially achieved cCR, and 27 had near-cCR. The median follow-up time was 48.4 months (10.2-110.3 months). The 5-year OS and CSS were 92.4% (95% CI 86.8-95.7%) and 96.6% (95% CI 92.2-98.5%), respectively. The 5-year OP-DFS(organ preservation adapted DFS) was 86.6% (95% CI 81.0-90.7%), and the 5-year OPR was 85.3% (95% CI 80.3-89.1%). The overall 5-year local regrowth rate and distant metastasis rate were 18.5% (95% CI 14.9-20.8%) and 8.2% (95% CI 5.4-12.5%), respectively. The 5-year local regrowth rate in the near-cCR group was higher than in the cCR group (41.6% vs. 16.4%, p<0.01), with a lower OPR rate (69.2 vs. 88.0%, p<0.001). However, there were no significant differences in OS, CSS, and OP-DFS between the two groups. 91% of local regrowths occurred within the intestinal lumen, 7.2% (4/56) occurred simultaneously in the intestinal lumen and mesentery, and 1.8% (1/56) occurred only in the mesentery. 82.1% of local regrowths occurred within 2 years, 91.0% occurred within 3 years, with a median regrowth time of 11.7 months (2.5-66.6 months). Among cases with local regrowth beyond 2 years, 30% (3/10) had mesenteric regrowth. The salvage success rate after local regrowth (conversion to disease-free status after salvage surgery) was 82.1% (46/56). 60.8% of distant metastases occurred within 2 years, 73.9% occurred within 3 years. Common sites included lung metastasis (65.2%), liver metastasis (34.8%), and bone metastasis (30.4%), with 26% involving multiple organs. 83.3% (5/6) of liver metastases occurred within 2 years, while lung and bone metastases spread out over 5 years follow-up. Among patients with local regrowth, 16.0% (9/56) developed distant metastases. The salvage success rates for local regrowth and distant metastasis were 82.1% (46/56) and 12.5% (3/23), respectively. Conclusions: Rectal cancer patients who achieve cCR or near-cCR after NAT and undergo W&W have favorable oncological outcomes and a high rate of organ preservation. Local regrowth and distant metastasis during W&W follow certain patterns, with a relatively high salvage rate for local regrowth. It emphasizes the importance of close follow-up and timely intervention during the W&W process.

Interpretation of Surgical Treatment Part of Updated NCCN Clinical Practice Guideline for Rectal Cancer

NCCN Guidelines® Insights: Rectal Cancer, Version 3.2024

Neoadjuvant Radiotherapy Improves Overall Survival for T3/4N+M0 Rectal Cancer Patients: a Population-Based Study of 20300 Patients

Long Term Outcome of Patients with Rectal Cancer with Complete Clinical Response or Near Complete Clinical Response after Neoadjuvant Therapy: A Multicenter Registry Study by Chinese Watch and Wait Database.

New opinions of colorectal cancer in 2010

[Review for the NCCN Clinical Guideline in Oncology of Rectal Cancer on Surgical Treatment from 2005 to 2015].

Multidisciplinary Assessment: a New Concept for Treatment of Rectal Cancer

Changing Patterns of Neoadjuvant Therapy for Locally Advanced Rectal Cancer: A Narrative Review

[Radiotherapy Standard and Progress in Locally Advanced Rectal Cancer].

Predictors and Risk Factors of Pathologic Complete Response Following Neoadjuvant Chemoradiotherapy for Rectal Cancer: A Population-Based Analysis

The Feasibility and Efficiency of Wait and See Policy for Patients with Complete Clinical Response Following Neoadjuvant Therapy in Rectal Cancer: A Prospective Cohort Study from China.

[Updates and interpretation on NCCN clinical practice guidelines for gastric cancer 2017 version 5]

Give Attention to Both Minimally Invasive Surgery and Precision Medicine to Promote the Scientificality on Individualized Clinical Practice of Rectal Cancer

Research Progress of Neoadjuvant Therapy for Locally Advanced Rectal Cancer

Interpretations of Practice Parameters for the Management of Rectal Cancer (2013 Released by American Society of Colon and Rectal Surgeons)

Advances in preoperative treatment of colorectal cancer

[Chinese expert consensus on the watch and wait strategy in rectal cancer patients after neoadjuvant treatment (2024 version)]

Nonoperative Management for Rectal Cancer

The Role of Targeted Drugs in the Neoadjuvant Chemotherapy for Colorectal Liver Metastases: an Update from the NCCN Guidelines

Current Status of Diagnosis and Management of Rectal Cancer in China

Surgical treatment following neoadjuvant chemoradiotherapy in locally advanced rectal cancer